查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
癫痫市场规模和预测、全球和区域份额、趋势和成长机会分析报告范围：按类型、给药途径、治疗类型、年龄层、配销通路和地理位置
市场调查报告书
商品编码
1450838

癫痫市场规模和预测、全球和区域份额、趋势和成长机会分析报告范围：按类型、给药途径、治疗类型、年龄层、配销通路和地理位置

Epilepsy Market Size and Forecasts, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Route of Administration, Treatment Type, Age Group, Distribution Channel, and Geography
出版日期: | 出版商: The Insight Partners | 英文 230 Pages | 订单完成后即时交付

价格

癫痫市场规模预计将从2022年的77亿美元成长到2030年的107亿美元；预计 2022 年至 2030 年CAGR为 4.1%。

癫痫是世界上最常见的慢性神经系统疾病之一。这种疾病与大脑异常电活动有关，影响超过 100 万美国育龄妇女。癫痫盛行率的上升和癫痫疗法开发投资的增加是导致癫痫市场扩大的重要因素。抗癫痫药物（AED）的施用通常被称为癫痫的一线治疗。约80%的癫痫患者来自发展中国家。无论是儿童或成人，癫痫的治疗大多是基于药物的使用（单一疗法或合併疗法），而其余的治疗方法，如手术、神经调节和生酮饮食，使用频率较低。然而，产品召回阻碍了癫痫市场的成长。

基于年龄组的见解

根据年龄组，癫痫市场分为成人和儿童。 2022 年，成人细分市场将占据更大的癫痫市场。预计 2022-2030 年市场CAGR将更高。成人更容易患癫痫，因为这种疾病的一些危险因素在成人中更常见；这些疾病包括影响大脑功能的疾病（例如阿兹海默症）、脑肿瘤、中风和头部受伤。根据美国疾病管制与预防中心 (CDC) 的数据，美国有 300 万 18 岁或以上的成年人患有活动性癫痫症。其中近 100 万成年人年龄在 55 岁或以上。随着人口老化，未来几年可能会有更多老年人患有癫痫。 2021 年，1.1% 的美国成年人（约 286 万名成年人）报告患有活动性癫痫。因此，药物和治疗策略通常优先考虑成年患者，与该年龄层癫痫的人口盛行率保持一致。

基于最终用户的见解

根据配销通路，癫痫市场分为医院药房、零售药房等。医院药局细分市场在 2022 年占据最大的癫痫市场份额。此外，零售药局细分市场预计在 2022 年至 2030 年期间将实现最高的CAGR。零售药局销售处方药、非处方药和一些快速消费品，并提供相关服务。现代零售药房连锁店是数位化、组织化和技术支援的，这使他们能够追踪药品库存并销售 100% 可靠的商品。此外，零售药局连锁店也为选择医疗索赔或保险申报的消费者提供加值服务。他们还可以被要求翻新以前的帐单或备忘录。此外，它们的位置使患者可以方便地配药并接受药剂师的咨询。

疾病管制与预防中心、世界卫生组织和加拿大神经健康慈善机构是准备癫痫市场报告时参考的主要和次要来源。

目录

第 1 章：简介

第 2 章：执行摘要

  • 重要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：癫痫市场格局

  • 概述
  • PEST分析

第 5 章：癫痫市场 - 主要市场动态

  • 癫痫市场 - 主要市场动态
  • 市场驱动因素
    • 癫痫盛行率上升
    • 增加癫痫疗法开发的投资
  • 市场限制
    • 产品召回
  • 市场机会
    • 组织所进行的意识计画激增
  • 未来的趋势
    • 基因疗法作为有前景的治疗方法
  • 驱动因素和限制的影响：

第 6 章：癫痫市场 - 全球市场分析

  • 癫痫市场收入，2022-2030

第 7 章：癫痫市场分析 - 按类型

  • 概述
  • 进行性肌阵挛癫痫
  • 反射性癫痫
  • 全身性癫痫
  • 其他

第 8 章：癫痫市场分析 - 按给药途径

  • 概述
  • 口服
  • 注射用
  • 其他的

第 9 章：癫痫市场分析 - 依治疗类型

  • 概述
  • 第一代药物
  • 第二代药物
  • 第三代药物

第 10 章：癫痫市场分析 - 按年龄组

  • 概述
  • 成人
  • 孩子们

第 11 章：癫痫市场分析 - 按配销通路

  • 概述
  • 医院药房
  • 零售药局
  • 其他的

第 12 章：癫痫市场 - 地理分析

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
    • 亚太地区其他地区
  • 中东和非洲
    • 中东和非洲
      • 沙乌地阿拉伯
      • 南非
      • 阿拉伯聯合大公国
      • 中东和非洲其他地区
      • 中东和非洲其他地区
  • 南美洲和中美洲
    • 南美洲和中美洲
      • 巴西
      • 阿根廷
      • 南美洲和中美洲其他地区
      • 南美洲和中美洲其他地区

第 13 章：产业格局

  • 概述
  • 癫痫市场的成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第 14 章：公司简介

  • Abbott Laboratories
  • Pfizer Inc
  • Eisai Co Ltd
  • UCB SA
  • CombiGene AB
  • LivaNova Plc
  • Novartis AG
  • Medtronic Plc
  • GSK Plc
  • H. Lundbeck AS

第 15 章：附录

Product Code: TIPRE00016405

The epilepsy market size is expected to grow from US$ 7.7 billion in 2022 to US$ 10.7 billion by 2030; it is projected to register a CAGR of 4.1% during 2022-2030.

Epilepsy is one of the most common chronic neurological disorders across the world. Associated with an abnormal electrical activity in the brain, this disorder affects over 1 million American women of childbearing age. The rising prevalence of epilepsy and increasing investments in the development of epilepsy therapies are noteworthy factors contributing to the expansion of the epilepsy market size. The administration of anti-epileptic drugs (AEDs) is usually referred to as the first-line treatment for epilepsy. Approximately 80% of the people suffering from epilepsy are from developing countries. In children as well as adults, the treatment of epilepsy is mostly based on the use of drugs (either in monotherapy or combined therapy), while the remaining treatment approaches, such as surgery, neuromodulation, and ketogenic diet, are used at a lesser frequency. However, the recall of products hinders the epilepsy market growth.

Age Group-Based Insights

Based on age group, the epilepsy market is segmented into adults and children. The adults segment held a larger epilepsy market share in 2022. It is further expected to register a higher CAGR in the market during 2022-2030. Epilepsy is more likely to develop in adults as some risk factors for this disease are more common in adults; these include diseases affecting brain function (such as Alzheimer's disease), brain tumors, strokes, and head injuries. According to the Centers for Disease Control and Prevention (CDC), 3 million adults aged 18 or older are living with active epilepsy in the US. Nearly 1 million of these adults are aged 55 or older. As the population ages, even more older people are likely to suffer from epilepsy in the coming years. In 2021, 1.1% of US adults (~2.86 million adults) reported active epilepsy. Thus, medications and treatment strategies often prioritize adult patients, aligning with the demographic prevalence of epilepsy in this age group.

End User-Based Insights

Based on distribution channel, the epilepsy market is segmented into hospital pharmacies, retail pharmacies, and others. The hospital pharmacies segment held the largest epilepsy market share in 2022. In addition, the retail pharmacies segment is expected to register the highest CAGR in the market during 2022-2030. Retail pharmacy stores sell prescription drugs, over-the-counter drugs, and some fast-moving consumer goods, along with providing related services. Modern retail pharmacy chains are digitized, organized, and tech-enabled, which allows them to track medication inventories and sell 100% reliable goods. In addition, retail pharmacy chains provide value-added services for consumers opting for medical claims or insurance filings. They can also be requested to refurbish previous bills or memos. Moreover, their locations make them accessible for patients to fill their prescriptions and receive counseling from pharmacists.

Centers for Disease Control and Prevention, the World Health Organization, and Neurological Health Charities Canada are among the primary and secondary sources referred to while preparing the epilepsy market report.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Epilepsy Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. Epilepsy Market - Key Market Dynamics

  • 5.1 Epilepsy Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Rising Prevalence of Epilepsy
    • 5.2.2 Increasing Investments in Development of Epilepsy Therapies
  • 5.3 Market Restraints
    • 5.3.1 Recall of Products
  • 5.4 Market Opportunities
    • 5.4.1 Surge in Awareness Programs Conducted by Organizations
  • 5.5 Future Trends
    • 5.5.1 Gene Therapy as Promising Treatment Approach
  • 5.6 Impact of Drivers and Restraints:

6. Epilepsy Market - Global Market Analysis

  • 6.1 Epilepsy Market Revenue (US$ Million), 2022-2030

7. Epilepsy Market Analysis - by Type

  • 7.1 Overview
  • 7.2 Progressive Myoclonic Epilepsy
    • 7.2.1 Overview
    • 7.2.2 Progressive Myoclonic Epilepsy: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Reflex Epilepsy
    • 7.3.1 Overview
    • 7.3.2 Reflex Epilepsy: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Generalized Epilepsy
    • 7.4.1 Overview
    • 7.4.2 Generalized Epilepsy: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Other
    • 7.5.1 Overview
    • 7.5.2 Other: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)

8. Epilepsy Market Analysis - by Route of Administration

  • 8.1 Overview
  • 8.2 Oral
    • 8.2.1 Overview
    • 8.2.2 Oral: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.3 Parenteral
    • 8.3.1 Overview
    • 8.3.2 Parenteral: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Others
    • 8.4.1 Overview
    • 8.4.2 Others: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)

9. Epilepsy Market Analysis - by Treatment Type

  • 9.1 Overview
  • 9.2 First Generation Drugs
    • 9.2.1 Overview
    • 9.2.2 First Generation Drugs: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.3 Second Generation Drugs
    • 9.3.1 Overview
    • 9.3.2 Second Generation Drugs: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Third Generation Drugs
    • 9.4.1 Overview
    • 9.4.2 Third Generation Drugs: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)

10. Epilepsy Market Analysis - by Age Group

  • 10.1 Overview
  • 10.2 Adult
    • 10.2.1 Overview
    • 10.2.2 Adult: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.3 Children
    • 10.3.1 Overview
    • 10.3.2 Children: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)

11. Epilepsy Market Analysis - by Distribution Channel

  • 11.1 Overview
  • 11.2 Hospital Pharmacies
    • 11.2.1 Overview
    • 11.2.2 Hospital Pharmacies: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
  • 11.3 Retail Pharmacies
    • 11.3.1 Overview
    • 11.3.2 Retail Pharmacies: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
  • 11.4 Others
    • 11.4.1 Overview
    • 11.4.2 Others: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)

12. Epilepsy Market - Geographical Analysis

  • 12.1 North America: Epilepsy Market
    • 12.1.1 Overview
    • 12.1.2 North America: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
      • 12.1.2.1 North America: Epilepsy Market - Revenue and Forecast Analysis - by Type
      • 12.1.2.2 North America: Epilepsy Market - Revenue and Forecast Analysis - by Route of Administration
      • 12.1.2.3 North America: Epilepsy Market - Revenue and Forecast Analysis - by Treatment Type
      • 12.1.2.4 North America: Epilepsy Market - Revenue and Forecast Analysis - by Age Group
      • 12.1.2.5 North America: Epilepsy Market - Revenue and Forecast Analysis - by Distribution Channel
    • 12.1.3 North America: Epilepsy Market - Revenue and Forecast Analysis - by Country
      • 12.1.3.1 United States: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.1.3.1.1 Overview
        • 12.1.3.1.2 United States: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.1.3.1.3 United States: Epilepsy Market Breakdown, by Type
        • 12.1.3.1.4 United States: Epilepsy Market Breakdown, by Route of Administration
        • 12.1.3.1.5 United States: Epilepsy Market Breakdown, by Treatment Type
        • 12.1.3.1.6 United States: Epilepsy Market Breakdown, by Age Group
        • 12.1.3.1.7 United States: Epilepsy Market Breakdown, by Distribution Channel
      • 12.1.3.2 Canada: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.1.3.2.1 Overview
      • 12.1.3.3 Canada: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.1.3.3.1 Canada: Epilepsy Market Breakdown, by Type
        • 12.1.3.3.2 Canada: Epilepsy Market Breakdown, by Route of Administration
        • 12.1.3.3.3 Canada: Epilepsy Market Breakdown, by Treatment Type
        • 12.1.3.3.4 Canada: Epilepsy Market Breakdown, by Age Group
        • 12.1.3.3.5 Canada: Epilepsy Market Breakdown, by Distribution Channel
      • 12.1.3.4 Mexico: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.1.3.4.1 Overview
      • 12.1.3.5 Mexico: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.1.3.5.1 Mexico: Epilepsy Market Breakdown, by Type
        • 12.1.3.5.2 Mexico: Epilepsy Market Breakdown, by Route of Administration
        • 12.1.3.5.3 Mexico: Epilepsy Market Breakdown, by Treatment Type
        • 12.1.3.5.4 Mexico: Epilepsy Market Breakdown, by Age Group
        • 12.1.3.5.5 Mexico: Epilepsy Market Breakdown, by Distribution Channel
  • 12.2 Europe: Epilepsy Market
    • 12.2.1 Overview
    • 12.2.2 Europe: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
      • 12.2.2.1 Europe: Epilepsy Market - Revenue and Forecast Analysis - by Type
      • 12.2.2.2 Europe: Epilepsy Market - Revenue and Forecast Analysis - by Route of Administration
      • 12.2.2.3 Europe: Epilepsy Market - Revenue and Forecast Analysis - by Treatment Type
      • 12.2.2.4 Europe: Epilepsy Market - Revenue and Forecast Analysis - by Age Group
      • 12.2.2.5 Europe: Epilepsy Market - Revenue and Forecast Analysis - by Distribution Channel
    • 12.2.3 Europe: Epilepsy Market - Revenue and Forecast Analysis - by Country
      • 12.2.3.1 United Kingdom: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.2.3.1.1 Overview
      • 12.2.3.2 United Kingdom: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.2.3.2.1 United Kingdom: Epilepsy Market Breakdown, by Type
        • 12.2.3.2.2 United Kingdom: Epilepsy Market Breakdown, by Route of Administration
        • 12.2.3.2.3 United Kingdom: Epilepsy Market Breakdown, by Treatment Type
        • 12.2.3.2.4 United Kingdom: Epilepsy Market Breakdown, by Age Group
        • 12.2.3.2.5 United Kingdom: Epilepsy Market Breakdown, by Distribution Channel
      • 12.2.3.3 Germany: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.2.3.3.1 Overview
      • 12.2.3.4 Germany: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.2.3.4.1 Germany: Epilepsy Market Breakdown, by Type
        • 12.2.3.4.2 Germany: Epilepsy Market Breakdown, by Route of Administration
        • 12.2.3.4.3 Germany: Epilepsy Market Breakdown, by Treatment Type
        • 12.2.3.4.4 Germany: Epilepsy Market Breakdown, by Age Group
        • 12.2.3.4.5 Germany: Epilepsy Market Breakdown, by Distribution Channel
      • 12.2.3.5 France: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.2.3.5.1 Overview
      • 12.2.3.6 France: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.2.3.6.1 France: Epilepsy Market Breakdown, by Type
        • 12.2.3.6.2 France: Epilepsy Market Breakdown, by Route of Administration
        • 12.2.3.6.3 France: Epilepsy Market Breakdown, by Treatment Type
        • 12.2.3.6.4 France: Epilepsy Market Breakdown, by Age Group
        • 12.2.3.6.5 France: Epilepsy Market Breakdown, by Distribution Channel
      • 12.2.3.7 Spain: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.2.3.7.1 Overview
      • 12.2.3.8 Spain: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.2.3.8.1 Spain: Epilepsy Market Breakdown, by Type
        • 12.2.3.8.2 Spain: Epilepsy Market Breakdown, by Route of Administration
        • 12.2.3.8.3 Spain: Epilepsy Market Breakdown, by Treatment Type
        • 12.2.3.8.4 Spain: Epilepsy Market Breakdown, by Age Group
        • 12.2.3.8.5 Spain: Epilepsy Market Breakdown, by Distribution Channel
      • 12.2.3.9 Italy: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.2.3.9.1 Overview
      • 12.2.3.10 Italy: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.2.3.10.1 Italy: Epilepsy Market Breakdown, by Type
        • 12.2.3.10.2 Italy: Epilepsy Market Breakdown, by Route of Administration
        • 12.2.3.10.3 Italy: Epilepsy Market Breakdown, by Treatment Type
        • 12.2.3.10.4 Italy: Epilepsy Market Breakdown, by Age Group
        • 12.2.3.10.5 Italy: Epilepsy Market Breakdown, by Distribution Channel
      • 12.2.3.11 Rest of Europe: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.2.3.11.1 Overview
      • 12.2.3.12 Rest of Europe: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.2.3.12.1 Rest of Europe: Epilepsy Market Breakdown, by Type
        • 12.2.3.12.2 Rest of Europe: Epilepsy Market Breakdown, by Route of Administration
        • 12.2.3.12.3 Rest of Europe: Epilepsy Market Breakdown, by Treatment Type
        • 12.2.3.12.4 Rest of Europe: Epilepsy Market Breakdown, by Age Group
        • 12.2.3.12.5 Rest of Europe: Epilepsy Market Breakdown, by Distribution Channel
  • 12.3 Asia Pacific: Epilepsy Market
    • 12.3.1 Overview
    • 12.3.2 Asia Pacific: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
      • 12.3.2.1 Asia Pacific: Epilepsy Market - Revenue and Forecast Analysis - by Type
      • 12.3.2.2 Asia Pacific: Epilepsy Market - Revenue and Forecast Analysis - by Route of Administration
      • 12.3.2.3 Asia Pacific: Epilepsy Market - Revenue and Forecast Analysis - by Treatment Type
      • 12.3.2.4 Asia Pacific: Epilepsy Market - Revenue and Forecast Analysis - by Age Group
      • 12.3.2.5 Asia Pacific: Epilepsy Market - Revenue and Forecast Analysis - by Distribution Channel
    • 12.3.3 Asia Pacific: Epilepsy Market - Revenue and Forecast Analysis - by Country
      • 12.3.3.1 China: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.3.3.1.1 Overview
      • 12.3.3.2 China: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.3.3.2.1 China: Epilepsy Market Breakdown, by Type
        • 12.3.3.2.2 China: Epilepsy Market Breakdown, by Route of Administration
        • 12.3.3.2.3 China: Epilepsy Market Breakdown, by Treatment Type
        • 12.3.3.2.4 China: Epilepsy Market Breakdown, by Age Group
        • 12.3.3.2.5 China: Epilepsy Market Breakdown, by Distribution Channel
      • 12.3.3.3 Japan: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.3.3.3.1 Overview
      • 12.3.3.4 Japan: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.3.3.4.1 Japan: Epilepsy Market Breakdown, by Type
        • 12.3.3.4.2 Japan: Epilepsy Market Breakdown, by Route of Administration
        • 12.3.3.4.3 Japan: Epilepsy Market Breakdown, by Treatment Type
        • 12.3.3.4.4 Japan: Epilepsy Market Breakdown, by Age Group
        • 12.3.3.4.5 Japan: Epilepsy Market Breakdown, by Distribution Channel
      • 12.3.3.5 India: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.3.3.5.1 Overview
      • 12.3.3.6 India: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.3.3.6.1 India: Epilepsy Market Breakdown, by Type
        • 12.3.3.6.2 India: Epilepsy Market Breakdown, by Route of Administration
        • 12.3.3.6.3 India: Epilepsy Market Breakdown, by Treatment Type
        • 12.3.3.6.4 India: Epilepsy Market Breakdown, by Age Group
        • 12.3.3.6.5 India: Epilepsy Market Breakdown, by Distribution Channel
      • 12.3.3.7 Australia: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.3.3.7.1 Overview
      • 12.3.3.8 Australia: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.3.3.8.1 Australia: Epilepsy Market Breakdown, by Type
        • 12.3.3.8.2 Australia: Epilepsy Market Breakdown, by Route of Administration
        • 12.3.3.8.3 Australia: Epilepsy Market Breakdown, by Treatment Type
        • 12.3.3.8.4 Australia: Epilepsy Market Breakdown, by Age Group
        • 12.3.3.8.5 Australia: Epilepsy Market Breakdown, by Distribution Channel
      • 12.3.3.9 South Korea: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.3.3.9.1 Overview
      • 12.3.3.10 South Korea: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.3.3.10.1 South Korea: Epilepsy Market Breakdown, by Type
        • 12.3.3.10.2 South Korea: Epilepsy Market Breakdown, by Route of Administration
        • 12.3.3.10.3 South Korea: Epilepsy Market Breakdown, by Treatment Type
        • 12.3.3.10.4 South Korea: Epilepsy Market Breakdown, by Age Group
        • 12.3.3.10.5 South Korea: Epilepsy Market Breakdown, by Distribution Channel
      • 12.3.3.11 Rest of Asia Pacific: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.3.3.11.1 Overview
      • 12.3.3.12 Rest of APAC: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.3.3.12.1 Rest of APAC: Epilepsy Market Breakdown, by Type
        • 12.3.3.12.2 Rest of APAC: Epilepsy Market Breakdown, by Route of Administration
        • 12.3.3.12.3 Rest of APAC: Epilepsy Market Breakdown, by Treatment Type
        • 12.3.3.12.4 Rest of APAC: Epilepsy Market Breakdown, by Age Group
        • 12.3.3.12.5 Rest of APAC: Epilepsy Market Breakdown, by Distribution Channel
  • 12.4 Middle East & Africa Epilepsy Market
    • 12.4.1 Overview
    • 12.4.2 Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
      • 12.4.2.1 Middle East and Africa: Epilepsy Market - Revenue and Forecast Analysis - by Type
      • 12.4.2.2 Middle East and Africa: Epilepsy Market - Revenue and Forecast Analysis - by Route of Administration
      • 12.4.2.3 Middle East and Africa: Epilepsy Market - Revenue and Forecast Analysis - by Treatment Type
      • 12.4.2.4 Middle East and Africa: Epilepsy Market - Revenue and Forecast Analysis - by Age Group
      • 12.4.2.5 Middle East and Africa: Epilepsy Market - Revenue and Forecast Analysis - by Distribution Channel
    • 12.4.3 Middle East and Africa: Epilepsy Market - Revenue and Forecast Analysis - by Country
      • 12.4.3.1 Saudi Arabia: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.4.3.1.1 Overview
      • 12.4.3.2 Saudi Arabia: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.4.3.2.1 Saudi Arabia: Epilepsy Market Breakdown, by Type
        • 12.4.3.2.2 Saudi Arabia: Epilepsy Market Breakdown, by Route of Administration
        • 12.4.3.2.3 Saudi Arabia: Epilepsy Market Breakdown, by Treatment Type
        • 12.4.3.2.4 Saudi Arabia: Epilepsy Market Breakdown, by Age Group
        • 12.4.3.2.5 Saudi Arabia: Epilepsy Market Breakdown, by Distribution Channel
      • 12.4.3.3 South Africa: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.4.3.3.1 Overview
      • 12.4.3.4 South Africa: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.4.3.4.1 South Africa: Epilepsy Market Breakdown, by Type
        • 12.4.3.4.2 South Africa: Epilepsy Market Breakdown, by Route of Administration
        • 12.4.3.4.3 South Africa: Epilepsy Market Breakdown, by Treatment Type
        • 12.4.3.4.4 South Africa: Epilepsy Market Breakdown, by Age Group
        • 12.4.3.4.5 South Africa: Epilepsy Market Breakdown, by Distribution Channel
      • 12.4.3.5 United Arab Emirates: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.4.3.5.1 Overview
      • 12.4.3.6 United Arab Emirates: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.4.3.6.1 United Arab Emirates: Epilepsy Market Breakdown, by Type
        • 12.4.3.6.2 United Arab Emirates: Epilepsy Market Breakdown, by Route of Administration
        • 12.4.3.6.3 United Arab Emirates: Epilepsy Market Breakdown, by Treatment Type
        • 12.4.3.6.4 United Arab Emirates: Epilepsy Market Breakdown, by Age Group
        • 12.4.3.6.5 United Arab Emirates: Epilepsy Market Breakdown, by Distribution Channel
      • 12.4.3.7 Rest of Middle East & Africa: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.4.3.7.1 Overview
      • 12.4.3.8 Rest of Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.4.3.8.1 Rest of Middle East and Africa: Epilepsy Market Breakdown, by Type
        • 12.4.3.8.2 Rest of Middle East and Africa: Epilepsy Market Breakdown, by Route of Administration
        • 12.4.3.8.3 Rest of Middle East and Africa: Epilepsy Market Breakdown, by Treatment Type
        • 12.4.3.8.4 Rest of Middle East and Africa: Epilepsy Market Breakdown, by Age Group
        • 12.4.3.8.5 Rest of Middle East and Africa: Epilepsy Market Breakdown, by Distribution Channel
  • 12.5 South & Central America: Epilepsy Market
    • 12.5.1 Overview
    • 12.5.2 South and Central America: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
      • 12.5.2.1 South and Central America: Epilepsy Market - Revenue and Forecast Analysis - by Type
      • 12.5.2.2 South and Central America: Epilepsy Market - Revenue and Forecast Analysis - by Route of Administration
      • 12.5.2.3 South and Central America: Epilepsy Market - Revenue and Forecast Analysis - by Treatment Type
      • 12.5.2.4 South and Central America: Epilepsy Market - Revenue and Forecast Analysis - by Age Group
      • 12.5.2.5 South and Central America: Epilepsy Market - Revenue and Forecast Analysis - by Distribution Channel
    • 12.5.3 South and Central America: Epilepsy Market - Revenue and Forecast Analysis - by Country
      • 12.5.3.1 Brazil: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.5.3.1.1 Overview
      • 12.5.3.2 Brazil: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.5.3.2.1 Brazil: Epilepsy Market Breakdown, by Type
        • 12.5.3.2.2 Brazil: Epilepsy Market Breakdown, by Route of Administration
        • 12.5.3.2.3 Brazil: Epilepsy Market Breakdown, by Treatment Type
        • 12.5.3.2.4 Brazil: Epilepsy Market Breakdown, by Age Group
        • 12.5.3.2.5 Brazil: Epilepsy Market Breakdown, by Distribution Channel
      • 12.5.3.3 Argentina: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.5.3.3.1 Overview
      • 12.5.3.4 Argentina: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.5.3.4.1 Argentina: Epilepsy Market Breakdown, by Type
        • 12.5.3.4.2 Argentina: Epilepsy Market Breakdown, by Route of Administration
        • 12.5.3.4.3 Argentina: Epilepsy Market Breakdown, by Treatment Type
        • 12.5.3.4.4 Argentina: Epilepsy Market Breakdown, by Age Group
        • 12.5.3.4.5 Argentina: Epilepsy Market Breakdown, by Distribution Channel
      • 12.5.3.5 Rest of South & Central America: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.5.3.5.1 Overview
      • 12.5.3.6 Rest of South and Central America: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.5.3.6.1 Rest of South and Central America: Epilepsy Market Breakdown, by Type
        • 12.5.3.6.2 Rest of South and Central America: Epilepsy Market Breakdown, by Route of Administration
        • 12.5.3.6.3 Rest of South and Central America: Epilepsy Market Breakdown, by Treatment Type
        • 12.5.3.6.4 Rest of South and Central America: Epilepsy Market Breakdown, by Age Group
        • 12.5.3.6.5 Rest of South and Central America: Epilepsy Market Breakdown, by Distribution Channel

13. Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies in Epilepsy Market
  • 13.3 Organic Growth Strategies
    • 13.3.1 Overview
  • 13.4 Inorganic Growth Strategies
    • 13.4.1 Overview

14. Company Profiles

  • 14.1 Abbott Laboratories
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Pfizer Inc
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Eisai Co Ltd
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 UCB SA
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 CombiGene AB
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 LivaNova Plc
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Novartis AG
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 Medtronic Plc
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 GSK Plc
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products and Services
    • 14.9.4 Financial Overview
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments
  • 14.10 H. Lundbeck AS
    • 14.10.1 Key Facts
    • 14.10.2 Business Description
    • 14.10.3 Products and Services
    • 14.10.4 Financial Overview
    • 14.10.5 SWOT Analysis
    • 14.10.6 Key Developments

15. Appendix

  • 15.1 About The Insight Partners

List Of Tables

  • Table 1. Epilepsy Market Segmentation
  • Table 2. North America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 3. North America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 4. North America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
  • Table 5. North America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
  • Table 6. North America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 7. United States: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 8. United States: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 9. United States: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
  • Table 10. United States: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
  • Table 11. United States: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 12. Canada: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 13. Canada: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 14. Canada: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
  • Table 15. Canada: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
  • Table 16. Canada: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 17. Mexico: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 18. Mexico: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 19. Mexico: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
  • Table 20. Mexico: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
  • Table 21. Mexico: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 22. Europe: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 23. Europe: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 24. Europe: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
  • Table 25. Europe: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
  • Table 26. Europe: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 27. United Kingdom: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 28. United Kingdom: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 29. United Kingdom: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
  • Table 30. United Kingdom: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
  • Table 31. United Kingdom: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 32. Germany: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 33. Germany: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 34. Germany: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
  • Table 35. Germany: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
  • Table 36. Germany: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 37. France: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 38. France: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 39. France: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
  • Table 40. France: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
  • Table 41. France: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 42. Spain: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 43. Spain: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 44. Spain: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
  • Table 45. Spain: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
  • Table 46. Spain: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 47. Italy: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 48. Italy: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 49. Italy: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
  • Table 50. Italy: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
  • Table 51. Italy: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 52. Rest of Europe: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 53. Rest of Europe: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 54. Rest of Europe: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
  • Table 55. Rest of Europe: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
  • Table 56. Rest of Europe: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 57. Asia Pacific: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 58. Asia Pacific: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 59. Asia Pacific: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
  • Table 60. Asia Pacific: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
  • Table 61. Asia Pacific: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 62. China: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 63. China: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 64. China: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
  • Table 65. China: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
  • Table 66. China: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 67. Japan: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 68. Japan: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 69. Japan: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
  • Table 70. Japan: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
  • Table 71. Japan: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 72. India: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 73. India: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 74. India: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
  • Table 75. India: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
  • Table 76. India: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 77. Australia: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 78. Australia: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 79. Australia: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
  • Table 80. Australia: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
  • Table 81. Australia: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 82. South Korea: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 83. South Korea: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 84. South Korea: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
  • Table 85. South Korea: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
  • Table 86. South Korea: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 87. Rest of APAC: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 88. Rest of APAC: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 89. Rest of APAC: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
  • Table 90. Rest of APAC: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
  • Table 91. Rest of APAC: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 92. Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 93. Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 94. Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
  • Table 95. Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
  • Table 96. Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 97. Saudi Arabia: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 98. Saudi Arabia: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 99. Saudi Arabia: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
  • Table 100. Saudi Arabia: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
  • Table 101. Saudi Arabia: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 102. South Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 103. South Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 104. South Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
  • Table 105. South Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
  • Table 106. South Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 107. United Arab Emirates: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 108. United Arab Emirates: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 109. United Arab Emirates: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
  • Table 110. United Arab Emirates: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
  • Table 111. United Arab Emirates: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 112. Rest of Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 113. Rest of Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 114. Rest of Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
  • Table 115. Rest of Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
  • Table 116. Rest of Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 117. South and Central America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 118. South and Central America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 119. South and Central America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
  • Table 120. South and Central America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
  • Table 121. South and Central America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 122. Brazil: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 123. Brazil: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 124. Brazil: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
  • Table 125. Brazil: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
  • Table 126. Brazil: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 127. Argentina: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 128. Argentina: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 129. Argentina: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
  • Table 130. Argentina: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
  • Table 131. Argentina: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 132. Rest of South and Central America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 133. Rest of South and Central America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 134. Rest of South and Central America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
  • Table 135. Rest of South and Central America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
  • Table 136. Rest of South and Central America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 137. Recent Organic Growth Strategies in Epilepsy Market
  • Table 138. Recent Inorganic Growth Strategies in the Epilepsy Market

List Of Figures

  • Figure 1. Epilepsy Market Segmentation, by Geography
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Epilepsy Market Revenue (US$ Million), 2022-2030
  • Figure 5. Epilepsy Market Revenue, Geography (US$ Mn), 2022 - 2030
  • Figure 6. Epilepsy Market Share (%) - by Type (2022 and 2030)
  • Figure 7. Progressive Myoclonic Epilepsy: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Reflex Epilepsy: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Generalized Epilepsy: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Other: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Epilepsy Market Share (%) - by Route of Administration (2022 and 2030)
  • Figure 12. Oral: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Parenteral: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Others: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Epilepsy Market Share (%) - by Treatment Type (2022 and 2030)
  • Figure 16. First Generation Drugs: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Second Generation Drugs: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Third Generation Drugs: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Epilepsy Market Share (%) - by Age Group (2022 and 2030)
  • Figure 20. Adult: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Children: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Epilepsy Market Share (%) - by Distribution Channel (2022 and 2030)
  • Figure 23. Hospital Pharmacies: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Retail Pharmacies: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Others: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. North America: Epilepsy Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 27. North America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 28. North America: Epilepsy Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 29. United States: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 30. Canada: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 31. Mexico: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 32. Europe: Epilepsy Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 33. Europe: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 34. Europe: Epilepsy Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 35. United Kingdom: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 36. Germany: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 37. France: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 38. Spain: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 39. Italy: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 40. Rest of Europe: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 41. Asia Pacific: Epilepsy Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 42. Asia Pacific: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 43. Asia Pacific: Epilepsy Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 44. China: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 45. Japan: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 46. India: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 47. Australia: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 48. South Korea: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 49. Rest of APAC: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 50. Middle East & Africa: Epilepsy Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 51. Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 52. Middle East and Africa: Epilepsy Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 53. Saudi Arabia: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 54. South Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 55. United Arab Emirates: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 56. Rest of Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 57. South & Central America: Epilepsy Market, By Key Country - Revenue (2022) (US$ Million)
  • Figure 58. South and Central America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 59. South and Central America: Epilepsy Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 60. Brazil: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 61. Argentina: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 62. Rest of South and Central America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 63. Growth Strategies in Epilepsy Market